Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis.
暂无分享,去创建一个
S. Kato | H. Hishida | S. Hiramitsu | M. Nomura | S. Morimoto | H Hishida | T. Ito | S Kato | S Morimoto | S Hiramitsu | M Nomura | T Ito | Masanori Nomura | Teruo Ito
[1] M. Rees,et al. Cardiac resuscitation with percutaneous cardiopulmonary support , 1992, The Lancet.
[2] D. Gray,et al. Percutaneous initiation of cardiopulmonary bypass. , 1983, The Annals of thoracic surgery.
[3] E. Topol,et al. Percutaneous support devices for high risk or complicated coronary angioplasty. , 1991, Journal of the American College of Cardiology.
[4] W. Wickemeyer,et al. Percutaneous cardiopulmonary bypass: application and indication for use. , 1989, The Annals of thoracic surgery.
[5] I. Morishima,et al. 916-86 Percutaneous Cardiopulmonary Bypass Support (PCPS) for the Treatment of Acute Fulminant Myocarditis Unresponsive to Maximum Medical Therapy , 1995 .
[6] W. Edwards,et al. Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.
[7] P. Teirstein,et al. Initial report of the National Registry of Elective Cardiopulmonary Bypass Supported Coronary Angioplasty. , 1990, Journal of the American College of Cardiology.
[8] J. Frederiksen,et al. Clinical experience with portable cardiopulmonary bypass in cardiac arrest patients. , 1990, The Annals of thoracic surgery.
[9] R. Emery,et al. Emergency cardiopulmonary bypass support in patients with cardiac arrest. , 1991, The Journal of thoracic and cardiovascular surgery.